We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.53%
3 Financials 14.18%
4 Consumer Discretionary 14.02%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBUU icon
2576
Malibu Boats
MBUU
$576M
-5,235
Closed -$286K
MDB icon
2577
MongoDB
MDB
$35.2B
-117,773
Closed -$9.6M
MDXG icon
2578
MiMedx Group
MDXG
$624M
-22,759
Closed -$141K
MMYT icon
2579
MakeMyTrip
MMYT
$5.67B
-134,327
Closed -$3.69M
PI icon
2580
Impinj
PI
$5.49B
-18,280
Closed -$454K
PRTA icon
2581
Prothena Corp
PRTA
$475M
-465,273
Closed -$6.09M
QMCO icon
2582
Quantum Corp
QMCO
$864M
-1,735
Closed -$83K
QUAD icon
2583
Quad
QUAD
$507M
-20,774
Closed -$433K
RPD icon
2584
Rapid7
RPD
$827M
-40,676
Closed -$1.5M
SONO icon
2585
Sonos
SONO
$1.86B
-578,586
Closed -$9.28M
SPOK icon
2586
Spok Holdings
SPOK
$230M
-14,409
Closed -$222K
STIM icon
2587
Neuronetics
STIM
$223M
-231,386
Closed -$7.42M
TGTX icon
2588
TG Therapeutics
TGTX
$7.58B
-39,297
Closed -$220K
TRI icon
2589
Thomson Reuters
TRI
$44.5B
-16,286
Closed -$862K
VET icon
2590
Vermilion Energy
VET
$1.73B
-6,200
Closed -$204K
ZS icon
2591
Zscaler
ZS
$28.7B
-233,876
Closed -$9.54M
TBRG
2592
DELISTED
TruBridge
TBRG
-8,391
Closed -$225K
VRN
2593
DELISTED
Veren
VRN
-15,916
Closed -$101K
OSG
2594
DELISTED
Overseas Shipholding Group Inc.
OSG
-4,790,798
Closed -$15.1M
MRNS
2595
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-102,165
Closed -$4.09M
TRVN
2596
DELISTED
Trevena, Inc.
TRVN
-306
Closed -$405K
CBAY
2597
DELISTED
Cymabay Therapeutics
CBAY
-410,967
Closed -$4.55M
DMK
2598
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-1,411
Closed -$346K
PRTK
2599
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-10,450
Closed -$101K
HMHC
2600
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-11,264
Closed -$79K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.